Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

NVO

Novo Nordisk ADR

Jan 09 • 02:16PM ET

59.08

+1.74 3.03 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI PID WCMI RVER PINK AQEC APIE

Scroll to Statements

Index	-	P/E	17.21	EPS (ttm)	3.43	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	12.77%
Market Cap	199.02B	Forward P/E	16.75	EPS next Y	3.53	Insider Trans	-	Shs Float	3.37B	Perf Month	27.44%
Enterprise Value	209.82B	PEG	2.97	EPS next Q	0.91	Inst Own	9.05%	Short Float	0.85%	Perf Quarter	0.68%
Income	15.29B	P/S	4.26	EPS this Y	15.83%	Inst Trans	-1.32%	Short Ratio	1.61	Perf Half Y	-14.29%
Sales	46.69B	P/B	9.82	EPS next Y	-3.68%	ROA	21.83%	Short Interest	28.49M	Perf YTD	16.12%
Book/sh	6.02	P/C	38.80	EPS next 5Y	5.64%	ROE	68.30%	52W High	93.80 -37.01%	Perf Year	-29.11%
Cash/sh	1.52	P/FCF	19.90	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	43.08 37.14%	Perf 3Y	-13.61%
Dividend Est.	1.78 (3.00%)	EV/EBITDA	9.11	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	2.78% 2.40%	Perf 5Y	65.42%
Dividend TTM	1.73 (2.92%)	EV/Sales	4.49	EPS Y/Y TTM	11.24%	Oper. Margin	42.41%	ATR (14)	1.79	Perf 10Y	103.44%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	75.91	Recom	2.21
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	13.81%	Beta	0.66	Target Price	60.45
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	19.03%	Rel Volume	1.67	Prev Close	57.34
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-0.32%	Avg Volume	17.65M	Price	59.08
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.41% -3.47%	Trades		Volume	22,016,343	Change	3.03%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral

Show Previous Ratings

Today 11:19AM	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (Reuters)
10:53AM	Rio Tinto, Glencore: Novo Nordisk: Stocks Overseas in Focus Friday (The Wall Street Journal)
10:34AM	Amazon Adds Novo Nordisk's Wegovy Pill to Pharmacy Platform (GuruFocus.com)
09:58AM	VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug (Zacks)
09:50AM	Amazon Pharmacy Begins Offering Wegovy Pill (The Wall Street Journal)
05:45PM	Loading…
Jan-08-26 05:45PM	Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
01:47PM	Novo Nordisk quietly loses key Washington insider amid pricing war (TheStreet)
09:35AM	Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1? (Zacks)
09:15AM	3 of the Best Stocks Under $100 to Buy in 2026 (Motley Fool)
08:00AM	Biotech Stocks' Dark Winter Is Over. What That Means For Investors. (Investor's Business Daily)
05:22AM	Matt Damon Says He Hasn't Been 'That Light Since High School' Following Gluten-Free Diet, Intense Training For 'The Odyssey' (Benzinga)
Jan-07-26 11:25AM	Novo Nordisk Stock Climbs After Expanding Veeva Vault CRM Partnership (GuruFocus.com)
Jan-06-26 08:50PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
06:31PM	Ro CEO Zach Reitano talks launch of Wegovy's GLP-1 pill (CNBC TV)
06:20PM	Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial? (Motley Fool)
01:28PM	Loading…
01:28PM	Eli Lilly, AI Drug-Discovery Company Nimbus Partner on Oral Obesity Treatment (The Wall Street Journal)
10:37AM	Daily Wegovy pill brings GLP-1 weight loss treatment to U.S. adults (TheStreet)
09:41AM	Can the US Launch of NVO's Wegovy Pill Reignite Momentum in 2026? (Zacks)
09:30AM	Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value? (Motley Fool)
Jan-05-26 04:01PM	Novo releases GLP-1 pill, bitcoin price rises, Qualcomm's chips (Yahoo Finance Video) +5.19%
03:43PM	Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs (decrypt)
02:09PM	Novo Nordisk launches GLP-1 pill, bank stocks rally (Yahoo Finance Video)
01:07PM	Eli Lilly Lags In The Weight-Loss Pill War. But It Has A Plan. (Investor's Business Daily)
12:28PM	Novo Nordisk Stock Rises as Wegovy Pill Hits the U.S. Market (GuruFocus.com)
11:54AM	Novo Nordisks Wegovy Pill Hits Pharmacies. Its the Latest Move in the Weight-Loss Showdown. (Barrons.com)
10:57AM	Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down. (MarketWatch)
10:37AM	LLY Up 28% in 3 Months: Is it the Right Time to Invest in the Stock? (Zacks)
09:57AM	Novo Nordisk Stock Rises on Launch of Weight-Loss Pills (The Wall Street Journal)
09:36AM	Stocks to Watch Monday: Chevron, Trump Media, AMD, Novo Nordisk (The Wall Street Journal)
09:20AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
08:42AM	Loading…
08:42AM	Novo Nordisks Wegovy Pill Now Broadly Available Across U.S. (The Wall Street Journal)
08:34AM	Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026? (Zacks)
08:00AM	Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America (PR Newswire)
07:36AM	Novo Nordisk launches Wegovy pill to US self-pay patients (Reuters Videos)
07:07AM	Novo Nordisk to Sell Wegovy Pill in U.S. Starting at $149 per Month (GuruFocus.com)
Jan-03-26 01:43PM	2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 (Motley Fool)
Jan-02-26 05:45PM	Why Novo Nordisk (NVO) Outpaced the Stock Market Today (Zacks) +5.19%
09:51AM	Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China (Zacks)
09:01AM	Here's How VKTX's Obesity Drug Is Moving Quickly Through Phase III (Zacks)
07:29AM	Here's Why SGA U.S. Large Cap Growth Strategy Sold Novo Nordisk (NVO) (Insider Monkey)
Jan-01-26 01:10AM	Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)'s Weight Loss Pill (Insider Monkey)
Dec-31-25 05:05PM	FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026 (MarketBeat)
03:08PM	In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s (Barrons.com)
08:07AM	The End of Shots? 5 Biotech Stocks Rethinking Diabetes (PR Newswire)
07:36AM	VNDA Obtains FDA Nod for Motion Sickness Drug, Stock Gains (Zacks)
Dec-30-25 02:32PM	Why Novo Nordisk Stock Dropped on Monday (Motley Fool)
11:57AM	Eli Lilly and Novo Nordisk Shares Dip After Cut Obesity Drug Prices in China (GuruFocus.com)
11:05AM	Can Amgen's MariTide Take on Leaders in the Obesity Space? (Zacks)
09:49AM	Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China (GuruFocus.com)
06:08AM	Novo and Lilly cut prices of weight-loss drugs in China (Reuters Videos)
Dec-29-25 11:59PM	Where is Novo Nordisk A/S (NVO) Headed? (Insider Monkey)
01:27PM	Joel Habener, Whose Research Helped Develop Weight-Loss Drugs, Dies at 88 (The Wall Street Journal)
12:45PM	Novo Nordisk Cuts Wegovy Prices in China Ahead of Patent Expiration (GuruFocus.com)
09:05AM	This Beaten-Down Stock Just Jumped By 8%. Time to Buy? (Motley Fool)
09:00AM	Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:46AM	The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug (Zacks)
07:06AM	Novo Nordisk reportedly cut Wegovy prices in China by half (Investing.com)
06:44AM	Novo Nordisk Cuts Wegovy Prices in China Ahead of Generic Threat (GuruFocus.com)
05:24AM	Novo Nordisk (NVO) Gets 9% Boost from Wegovy Pill OK (Insider Monkey)
04:43AM	The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. (Motley Fool)
Dec-28-25 02:17PM	Novo Nordisk just pulled off something nobody saw coming (TheStreet)
Dec-26-25 02:56PM	Christmas Week Brings S&P 500 Records, Tech Volatility (Schaeffer's Research)
01:42PM	Should You Invest in Ozempic Maker Novo Nordisk in 2026? (Motley Fool)
12:42PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
12:41PM	Bear of the Day: Novo Nordisk (NVO) (Zacks)
12:05PM	GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds (GuruFocus.com)
11:37AM	Eli Lillys New Drug Data Sets Up a High-Stakes 2026 (MarketBeat)
10:10AM	Stock Market Hits Record Highs On Nvidia, Google, GDP Data: Weekly Review (Investor's Business Daily)
08:01AM	Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access (GuruFocus.com)
Dec-25-25 12:05PM	Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? (Motley Fool)
09:00AM	As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? (Barchart)
06:40AM	Novo, Lilly race to cement lead in Indias obesity drug market, Reuters says (TipRanks)
12:47AM	Asian shares are mixed after US stocks drift to more records (Associated Press Finance)
Dec-24-25 05:46PM	Weight-loss pill approval spurs food industry overhaul (Reuters Videos)
05:45PM	Novo Nordisk (NVO) Rises Higher Than Market: Key Facts (Zacks)
10:49AM	NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly? (Zacks)
06:25AM	Novos Wegovy pill is planned to enter U.S. self-pay channels, Reuters says (TipRanks)
03:47AM	Company News for Dec 24, 2025 (Zacks)
Dec-23-25 06:55PM	Closing Bell Movers: Novo Nordisk gains on Wegovy FDA update (TipRanks) +7.30%
06:17PM	Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez (CNBC TV)
06:00PM	Novo Nordisk says FDA approved Wegovy pill to reduce body weight (TipRanks)
05:23PM	Why Novo Nordisk Stock Popped Today (Motley Fool)
05:17PM	Dr. Ashish Jha talks Novo Nordisk getting approval for Wegovy pill (CNBC TV)
05:11PM	Stocks to Watch Tuesday Recap: Novo Nordisk, Huntington Ingalls, ServiceNow (The Wall Street Journal)
05:06PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:55PM	Heard on the Street Recap: A Dose of Optimism (The Wall Street Journal)
04:48PM	Stock Market Today: Dow Higher As S&P 500 Scores Record; Nvidia Clears Key Level (Live Coverage) (Investor's Business Daily)
04:41PM	How major US stock indexes fared Tuesday, 12/23/2025 (Associated Press Finance)
04:24PM	ServiceNow to acquire Armis for $7.75B, gold & silver record highs (Yahoo Finance Video)
04:15PM	These Stocks Moved the Most Today: Novo Nordisk, ServiceNow, Micron, DJT, Freeport-McMoRan, Zim, and More (Barrons.com)
04:05PM	Wegovy Pill Approval Sends Novo Nordisk Stock Soaring. What It Means for Eli Lilly. (Barrons.com)
04:03PM	Stock market today: S&P 500 notches latest 2025 record as Wall Street's winning streak reaches 4 (Yahoo Finance)
04:01PM	Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug (Investor's Business Daily)
03:59PM	Stock Market Today: S&P 500 Eyes Record High; Analyst Names Reddit 2026 Top Pick (Live Coverage) (Investor's Business Daily)
03:16PM	Novo Nordisk is still worried about revenue growth next year despite obesity pill: BMO's Seigerman (CNBC TV)
02:51PM	These Stocks Are Moving the Most Today: Novo Nordisk, ServiceNow, Micron, DJT, Freeport-McMoRan, Zim, and More (Barrons.com)
02:24PM	Stock market today: S&P 500, Nasdaq, Dow turn higher after surprise GDP growth trims rate-cut bets (Yahoo Finance)
01:23PM	Novo Nordisk Strikes First With Oral Wegovy But Can It Outrun Lillys Looming Pill? (24/7 Wall St.)
01:04PM	Stock Market Today: Nasdaq Leads After GDP Surprise; Solar Stock Dives (Live Coverage) (Investor's Business Daily)
12:17PM	Arrival of GLP-1 weight-loss pill creates new headache for food, drink makers (Just Food)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience